Evelyne May
- Oncology top 2%
- Cancer-related Molecular Pathways 17
- Polyomavirus and related diseases 9
- Biotechnology top 2%
- Cancer Research and Treatments 9
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 3
- Molecular Biology top 5%
- Cell death mechanisms and regulation 4
- Genetics top 10%
- Virus-based gene therapy research 6
-
- Bacteriophages and microbial interactions 4
-
- Plant Virus Research Studies 4
- Co-authors
- Pierre MayGeorge KhouryVéronique BouvardJean‐Christophe BourdonPascal DranéAnne BravardBrigitte DebuireThierry Soussi
- Cited by
- OncologyBiotechnologyCancer Research
- Partner nations
- FranceUnited StatesSpain
In The Last Decade
Evelyne May
40 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 105
- Oncology 1.2k
- Biotechnology 233
- Cancer Research 347
- Molecular Biology 1.3k
- Genetics 314
Countries citing papers authored by Evelyne May
This map shows the geographic impact of Evelyne May's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evelyne May with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evelyne May more than expected).
Fields of papers citing papers by Evelyne May
This network shows the impact of papers produced by Evelyne May. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evelyne May. The network helps show where Evelyne May may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Evelyne May, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 4 | |
| 2 | 2004 | 32 | |
| 3 | 2003 | 8 | |
| 4 | 2002 | 16 | |
| 5 | 2001 | 143 | |
| 6 | 2000 | 103 | |
| 7 | 2000 | 24 | |
| 8 | 1999 | 35 | |
| 9 | Twenty years of p53 research: structural and functional aspects of the p53 proteinbreakdown → | 1999 | 533 |
| 10 | 1997 | 134 | |
| 11 | 1995 | 21 | |
| 12 | 1995 | 65 | |
| 13 | 1995 | 54 | |
| 14 | 1993 | 89 | |
| 15 | 1991 | 9 | |
| 16 | 1991 | 11 | |
| 17 | 1988 | 108 | |
| 18 | 1986 | 11 | |
| 19 | 1984 | 4 | |
| 20 | 1977 | 167 |
About Evelyne May
Evelyne May is a scholar working on Oncology, Biotechnology and Molecular Biology, having authored 40 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (17 papers), Cancer Research and Treatments (9 papers), Polyomavirus and related diseases (9 papers), Virus-based gene therapy research (6 papers), Bacteriophages and microbial interactions (4 papers), Cell death mechanisms and regulation (4 papers), Plant Virus Research Studies (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). The work is most often cited by research in Oncology (1.2k citations), Biotechnology (233 citations) and Cancer Research (347 citations). Evelyne May has collaborated with scholars based in France, United States and Spain. Frequent co-authors include Pierre May, George Khoury, Véronique Bouvard, Jean‐Christophe Bourdon, Pascal Drané, Anne Bravard, Brigitte Debuire, Thierry Soussi, Claude Caron de Fromentel and Elisheva Yonish-Rouach. Their work appears in journals such as Oncogene, Nucleic Acids Research, Virology, Molecular and Cellular Biology and Journal of Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.